This is a K-award resubmission (Mentored Research Scientist Development Award, KOl) that is designed to enable the applicant to acquire a richer clinical understanding of the complex interplay between psychiatric and medical illness, to integrate clinical knowledge with quantitative expertise, and to develop neuroimaging methods that are more clinically useful. The candidate is an Assistant Professor of Radiology and physicist in the positron emission tomography (PET) facility at the University of Pittsburgh. The applicant's primary research experience has been in kinetic modeling and methods development for PET imaging and this quantitative expertise has acted as a bridge between different clinical disciplines. Past and present collaborations include PET studies of medically healthy depressed subjects and skeletal muscle function in subjects with diabetes. These experiences led the candidate to become interested in the link between depression and diabetes. The KOl research will use PET imaging to study diabetes as a co-existing medical illness in elderly depressives. PET measures of serotonin 5-HT1A receptor binding ({11C]WAY 100635) wifi be obtained in subjects with adult-onset type 2 diabetes, 40-80 years of age, who are (n=25) and are not (n=25) depressed. Data interpretation will be facilitated by cerebral blood flow (~l50]water) data that also will be acquired for each subject and by the availability of 5-HT1A and cerebral blood flow measures in medically healthy mid-life and elderly subjects, without and with depression (through ongoing University of Pittsburgh collaborations).

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Scientist Development Award - Research & Training (K01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BDCN-6 (01))
Program Officer
Wynne, Debra K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Medicine
United States
Zip Code
Wagner, Amy K; Scanlon, Joelle M; Becker, Carl R et al. (2014) The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI. J Cereb Blood Flow Metab 34:1328-39
Mathis, Chester A; Kuller, Lewis H; Klunk, William E et al. (2013) In vivo assessment of amyloid-? deposition in nondemented very elderly subjects. Ann Neurol 73:751-61
D'Angelo, Gina M; Weissfeld, Lisa A (2013) Application of copulas to improve covariance estimation for partial least squares. Stat Med 32:685-96
Mathis, Chester A; Mason, N Scott; Lopresti, Brian J et al. (2012) Development of positron emission tomography ?-amyloid plaque imaging agents. Semin Nucl Med 42:423-32
Wolk, David A; Price, Julie C; Saxton, Judy A et al. (2009) Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 65:557-68
Cohen, Ann D; Price, Julie C; Weissfeld, Lisa A et al. (2009) Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci 29:14770-8
Aizenstein, Howard Jay; Nebes, Robert D; Saxton, Judith A et al. (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65:1509-17
Rosario, Bedda L; Ziolko, Scott K; Weissfeld, Lisa A et al. (2008) Assessment of parameter settings for SPM5 spatial normalization of structural MRI data: application to type 2 diabetes. Neuroimage 41:363-70
Raji, Cyrus A; Becker, James T; Tsopelas, Nicholas D et al. (2008) Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B. J Neurosci Methods 172:277-82
Klunk, William E; Mathis, Chester A (2008) Whatever happened to Pittsburgh Compound-A? Alzheimer Dis Assoc Disord 22:198-203

Showing the most recent 10 out of 16 publications